662 related articles for article (PubMed ID: 18539958)
1. Pancreatic cancer stem cells.
Lee CJ; Dosch J; Simeone DM
J Clin Oncol; 2008 Jun; 26(17):2806-12. PubMed ID: 18539958
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.
Tanase CP; Neagu AI; Necula LG; Mambet C; Enciu AM; Calenic B; Cruceru ML; Albulescu R
World J Gastroenterol; 2014 Aug; 20(31):10790-801. PubMed ID: 25152582
[TBL] [Abstract][Full Text] [Related]
3. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal.
Rodova M; Fu J; Watkins DN; Srivastava RK; Shankar S
PLoS One; 2012; 7(9):e46083. PubMed ID: 23029396
[TBL] [Abstract][Full Text] [Related]
4. Identification of human pancreatic cancer stem cells.
Li C; Lee CJ; Simeone DM
Methods Mol Biol; 2009; 568():161-73. PubMed ID: 19582426
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract][Full Text] [Related]
6. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
[TBL] [Abstract][Full Text] [Related]
7. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.
Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł
Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978
[TBL] [Abstract][Full Text] [Related]
8. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells.
Vaz AP; Ponnusamy MP; Rachagani S; Dey P; Ganti AK; Batra SK
Br J Cancer; 2014 Jul; 111(3):486-96. PubMed ID: 25003666
[TBL] [Abstract][Full Text] [Related]
9. Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice.
Li L; Hao X; Qin J; Tang W; He F; Smith A; Zhang M; Simeone DM; Qiao XT; Chen ZN; Lawrence TS; Xu L
Gastroenterology; 2014 Apr; 146(4):1108-18. PubMed ID: 24397969
[TBL] [Abstract][Full Text] [Related]
10. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
Kakarala M; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
[TBL] [Abstract][Full Text] [Related]
11. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
12. Nicotine induces self-renewal of pancreatic cancer stem cells via neurotransmitter-driven activation of sonic hedgehog signalling.
Al-Wadei MH; Banerjee J; Al-Wadei HA; Schuller HM
Eur J Cancer; 2016 Jan; 52():188-96. PubMed ID: 26689865
[TBL] [Abstract][Full Text] [Related]
13. Isolation, identification, and characterization of cancer stem cells: A review.
Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
[TBL] [Abstract][Full Text] [Related]
14. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
[TBL] [Abstract][Full Text] [Related]
15. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
[TBL] [Abstract][Full Text] [Related]
16. Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway.
Verma RK; Yu W; Singh SP; Shankar S; Srivastava RK
Nanomedicine; 2015 Nov; 11(8):2061-70. PubMed ID: 26199979
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer stem cells: new insights and perspectives.
Dorado J; Lonardo E; Miranda-Lorenzo I; Heeschen C
J Gastroenterol; 2011 Aug; 46(8):966-73. PubMed ID: 21698355
[TBL] [Abstract][Full Text] [Related]
19. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.
Zhu J; He J; Liu Y; Simeone DM; Lubman DM
J Proteome Res; 2012 Apr; 11(4):2272-81. PubMed ID: 22335271
[TBL] [Abstract][Full Text] [Related]
20. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
